Juliet Schurder1, Tiphaine Goulenok1, Romain Jouenne1, Antoine Dossier1, Damien Van Gysel2, Thomas Papo3, Karim Sacre4. 1. Département de médecine interne, hôpital Bichat, Assistance publique-Hôpitaux de Paris, 75018 Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, 75018 Paris, France. 2. Université Paris Diderot, PRES Sorbonne Paris Cité, 75018 Paris, France; Département d'épidémiologie, biostatistiques et recherche clinique, hôpital Bichat, Assistance publique-Hôpitaux de Paris, 75018 Paris, France. 3. Département de médecine interne, hôpital Bichat, Assistance publique-Hôpitaux de Paris, 75018 Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, 75018 Paris, France; Inserm U1149, laboratoire d'excellence INFLAMEX, 75018 Paris, France; Département hospitalo-universitaire FIRE (fibrosis, inflammation and remodelling in renal and respiratory diseases), 75018 Paris, France. 4. Département de médecine interne, hôpital Bichat, Assistance publique-Hôpitaux de Paris, 75018 Paris, France; Université Paris Diderot, PRES Sorbonne Paris Cité, 75018 Paris, France; Inserm U1149, laboratoire d'excellence INFLAMEX, 75018 Paris, France; Département hospitalo-universitaire FIRE (fibrosis, inflammation and remodelling in renal and respiratory diseases), 75018 Paris, France. Electronic address: karim.sacre@aphp.fr.
Abstract
OBJECTIVE: Our study aimed to analyze the risk factors associated with the occurrence and severity of pneumococcal infection (PI) in systemic lupus erythematosus (SLE) patients. METHODS: Medical records of all SLE patients admitted in our department from January 2005 to December 2014 were retrospectively reviewed. SLE patients were separated in 2 groups according to whether they had PI or not. Medical records of all consecutive patients (with and without SLE) admitted in our department for PI over the same period of time were also reviewed. Clinical characteristics associated with PI occurrence and severity were analyzed in SLE patients. RESULTS: One hundred and ninety SLE patients (42.2+14.9 years; 87.4% females) were hospitalized over a 10-year period. PI was the reason for admission in 6 (3.2%) patients, including 5 cases of invasive infection. With a follow-up of 2112.8 patient-years for the total cohort, incidence of invasive PI in SLE was of 236/100,000 patient-years. PI occurred at a younger age (43.5+14.9 versus 65.3+18.7 years, P<0.01) and were more severe, with a higher frequency of invasive infection (P<0.001) and higher need for ICU admission (P<0.05) in SLE as compared to non SLE patients. Risk factors associated with PI in SLE patients were a serum gammaglobulin level<5g/L (P<0.01) and a past history of lupus nephritis (P<0.05), only. Steroids (P<0.001) and immunosuppressive drugs (P<0.05) were associated with infection severity. CONCLUSION: SLE is a disease of high susceptibility for invasive pneumococcal infections. Our study points to the need for vaccination against Streptococcus pneumoniae in SLE.
OBJECTIVE: Our study aimed to analyze the risk factors associated with the occurrence and severity of pneumococcal infection (PI) in systemic lupus erythematosus (SLE) patients. METHODS: Medical records of all SLEpatients admitted in our department from January 2005 to December 2014 were retrospectively reviewed. SLEpatients were separated in 2 groups according to whether they had PI or not. Medical records of all consecutive patients (with and without SLE) admitted in our department for PI over the same period of time were also reviewed. Clinical characteristics associated with PI occurrence and severity were analyzed in SLEpatients. RESULTS: One hundred and ninety SLEpatients (42.2+14.9 years; 87.4% females) were hospitalized over a 10-year period. PI was the reason for admission in 6 (3.2%) patients, including 5 cases of invasive infection. With a follow-up of 2112.8 patient-years for the total cohort, incidence of invasive PI in SLE was of 236/100,000 patient-years. PI occurred at a younger age (43.5+14.9 versus 65.3+18.7 years, P<0.01) and were more severe, with a higher frequency of invasive infection (P<0.001) and higher need for ICU admission (P<0.05) in SLE as compared to non SLEpatients. Risk factors associated with PI in SLEpatients were a serum gammaglobulin level<5g/L (P<0.01) and a past history of lupus nephritis (P<0.05), only. Steroids (P<0.001) and immunosuppressive drugs (P<0.05) were associated with infection severity. CONCLUSION:SLE is a disease of high susceptibility for invasive pneumococcal infections. Our study points to the need for vaccination against Streptococcus pneumoniae in SLE.
Authors: Hannah M Garcia Garrido; Albert Vollaard; Geert R D'Haens; Phyllis I Spuls; Frederike J Bemelman; Michael W Tanck; Godelieve J de Bree; Bob Meek; Martin P Grobusch; Abraham Goorhuis Journal: Vaccines (Basel) Date: 2022-05-17
Authors: Chiara Cantarelli; Chiara Guglielmo; Susan Hartzell; Fadi El Salem; Sofia Andrighetto; Victor P Gazivoda; Enrico Fiaccadori; Gaetano La Manna; Gianluigi Zaza; Jeremy Leventhal; Ioannis Tassiulas; Paolo Cravedi Journal: Front Immunol Date: 2019-11-20 Impact factor: 7.561
Authors: Victoria Furer; Christien Rondaan; Marloes Heijstek; Sander van Assen; Marc Bijl; Nancy Agmon-Levin; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha Crnkic Kapetanovic; Jacob M van Laar; Annette Ladefoged de Thurah; Robert Landewé; Anna Molto; Ulf Müller-Ladner; Karen Schreiber; Leo Smolar; Jim Walker; Klaus Warnatz; Nico M Wulffraat; Ori Elkayam Journal: RMD Open Date: 2019-09-19